HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jaroslaw D Kasprzak Selected Research

Infarction (Infarctions)

1/2016Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
2/2009Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jaroslaw D Kasprzak Research Topics

Disease

3ST Elevation Myocardial Infarction
01/2020 - 02/2009
3Thrombosis (Thrombus)
12/2017 - 06/2007
3Hemorrhage
01/2016 - 08/2013
3Acute Coronary Syndrome
08/2014 - 08/2013
2Heart Failure
01/2023 - 03/2017
2Coronary Artery Disease (Coronary Atherosclerosis)
08/2021 - 10/2013
2Infarction (Infarctions)
01/2016 - 02/2009
2Rupture
01/2016 - 03/2010
2Myocardial Infarction
08/2014 - 02/2009
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2003 - 04/2002
1Pulmonary Arterial Hypertension
10/2022
1COVID-19
10/2022
1Disease Progression
10/2022
1Aortic Valve Stenosis (Aortic Stenosis)
11/2021
1Coronary Vasospasm (Coronary Artery Vasospasm)
08/2021
1Tetralogy of Fallot (Fallot Tetralogy)
08/2021
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2021
1Diastolic Heart Failure
08/2021
1Heart Valve Diseases (Valvular Heart Disease)
08/2021
1Anthracosis
09/2018
1Fistula
12/2017
1Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2017
1Cardiac Arrhythmias (Arrythmia)
01/2016
1Hypersensitivity (Allergy)
01/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2013
1Pathologic Constriction (Stenosis)
10/2013
1Ventricular Heart Septal Defects (Ventricular Septal Defect)
03/2010
1Pain (Aches)
03/2010
1Cardiogenic Shock
03/2010
1Cardiovascular Diseases (Cardiovascular Disease)
03/2010
1Cardiac Tamponade
03/2010
1Reperfusion Injury
02/2009
1Heart Neoplasms
03/2006
1Atrial Fibrillation
04/2002

Drug/Important Bio-Agent (IBA)

3RB 006IBA
01/2016 - 08/2013
3Heparin (Liquaemin)FDA LinkGeneric
08/2014 - 08/2013
2DobutamineFDA LinkGeneric
11/2021 - 04/2002
2Factor IXa (Coagulation Factor IXa)IBA
01/2016 - 08/2014
2RB 007IBA
01/2016 - 08/2014
1Complement System Proteins (Complement)IBA
01/2023
1EstersIBA
08/2021
1salicylhydroxamic acid (SHAM)IBA
03/2017
1bivalirudin (Angiomax)FDA Link
01/2016
1Dipyridamole (Persantine)FDA LinkGeneric
10/2013
1contrast agent BR1IBA
10/2013
1Vasodilator Agents (Vasodilators)IBA
10/2013
1Sulfur HexafluorideIBA
10/2013
1Dichlorodiphenyldichloroethane (DDD)IBA
03/2010
1Peptides (Polypeptides)IBA
02/2009
1FibrinIBA
02/2009
1GadoliniumIBA
02/2009
1Troponin IIBA
02/2009
1AnticoagulantsIBA
03/2006
1DystrophinIBA
10/2003

Therapy/Procedure

5Percutaneous Coronary Intervention
01/2020 - 02/2009
3Therapeutics
10/2022 - 01/2016
2Stents
12/2017 - 01/2016
1Drug Therapy (Chemotherapy)
08/2021
1Radiotherapy
08/2021
1Surgical Instruments (Clip)
09/2018
1Biological Therapy
03/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2017
1Microbubbles
10/2013
1Anticoagulation Reversal
08/2013
1Counterpulsation (External Counterpulsation)
03/2010
1Thrombolytic Therapy
06/2007
1Heart Transplantation (Grafting, Heart)
04/2002